Global Steroid-Free Nasal Sprays Market Size study, By Product Type (Nasal Antihistamine Sprays, Nasal Decongestant Sprays, Nasal Anticholinergic Sprays, Nasal Cromolyn Sodium Sprays, Others), By Distribution Channel (Institutional Sales, Retail Sales), a

Global Steroid-Free Nasal Sprays Market Size study, By Product Type (Nasal Antihistamine Sprays, Nasal Decongestant Sprays, Nasal Anticholinergic Sprays, Nasal Cromolyn Sodium Sprays, Others), By Distribution Channel (Institutional Sales, Retail Sales), and Regional Forecasts 2022-2028

Global Steroid-Free Nasal Sprays Market is valued at approximately USD 7.7 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6.3% over the forecast period 2022-2028. Steroid-free nasal sprays are a variety of nasal spare that is used to deliver steroid-free medications in the nasal cavities or systemically. These nasal sprays are used for treating conditions such as allergic rhinitis and nasal congestion. The rising healthcare expenditure, increasing incidences of allergic reactions, coupled with the growing awareness of palliative care services are the key factors that are soaring the market demand across the globe. According to the Asthma and Allergy Foundation of America, in 2018, it was estimated that around 24 million people across the United States were diagnosed with seasonal allergic rhinitis. And, as per World Allergy Organization, rhinitis affected between 10% and 30 % of the population worldwide. In addition, it is projected that the global allergic rhinitis treatment segment reaches USD 7.3 billion by 2024 as per Statista. Therefore, the rising prevalence of allergic rhinitis is exhibiting a positive influence on the growth of the global market in the impending years. However, several side effects are associated with steroid-free nasal sprays, and the imposition of government regulations impedes the growth of the market over the forecast period of 2022-2028. Also, the increasing investments in the research & development activities and rising number of strategic actions by the key market players such as mergers & acquisitions, product launches, etc. are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Steroid-Free Nasal Sprays Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the rising healthcare expenditure and presence of leading market players. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the growing prevalence of allergic rhinitis, as well as growth of the pharmaceutical industry, would create lucrative growth prospects for the Steroid-Free Nasal Sprays Market across the Asia-Pacific region.

Major market players included in this report are:
Janssen Pharmaceutical, Inc.
Astra Zeneca Plc.
Cipla Ltd.
Glenmark Pharmaceuticals
GlaxoSmithKline Plc.
Novartis International AG
Procter & Gamble
Sanofi S.A. (Sanofi-aventis LLC.)
Boehringer Ingelheim GmbH
AdvaCare Pharma

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Nasal Antihistamine Sprays
Nasal Decongestant Sprays
Nasal Anticholinergic Sprays
Nasal Cromolyn Sodium Sprays
Others
By Distribution Channel:
Institutional Sales
Retail Sales
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Steroid-Free Nasal Sprays Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Janssen Pharmaceutical, Inc.
Astra Zeneca Plc.
Cipla Ltd.
Glenmark Pharmaceuticals
GlaxoSmithKline Plc.
Novartis International AG
Procter & Gamble
Sanofi S.A. (Sanofi-aventis LLC.)
Boehringer Ingelheim GmbH
AdvaCare Pharma

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.